<SEC-DOCUMENT>0001193125-18-313968-index.html : 20181031 <SEC-HEADER>0001193125-18-313968.hdr.sgml : 20181031 <ACCEPTANCE-DATETIME>20181031162458 ACCESSION NUMBER: 0001193125-18-313968 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20181031 DATE AS OF CHANGE: 20181031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 181150645 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 </SEC-HEADER> <DOCUMENT> <TYPE>10-Q/A <SEQUENCE>1 <FILENAME>d645222d10qa.htm <DESCRIPTION>10-Q/A <TEXT> Document 1 - file: d645222d10qa.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>d645222dex21.htm <DESCRIPTION>EX-2.1 <TEXT> Document 2 - file: d645222dex21.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>3 <FILENAME>d645222dex311.htm <DESCRIPTION>EX-31.1 <TEXT> Document 3 - file: d645222dex311.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>4 <FILENAME>d645222dex312.htm <DESCRIPTION>EX-31.2 <TEXT> Document 4 - file: d645222dex312.htm
</DOCUMENT> </SEC-DOCUMENT>